Ideas to Action:

Independent research for global prosperity

CGD in the News

The Decade In Global Health: New Drugs, Faster Trials, Social Media To The Rescue (National Public Radio)

December 24, 2019

From the article:

“A vaccine deals a blow to meningitis A:

In 2010, a vaccine called MenAfriVac was approved for use by the World Health Organization. By 2016 was available in all 26 countries of Africa's "meningitis belt," a group of 26 countries that suffer from a wave of meningitis A outbreaks about every five to 14 years. The disease causes protective membranes around the brain to swell, with symptoms of fever, headache and neck stiffness, according to the Center for Global Development's book, ‘Millions Saved.’

‘You wake up in the morning normal, and you can be dead by afternoon,’ says Amanda Glassman, executive vice president of the Center for Global Development and co-author of the book.

Because of the vaccine, the disease has been reduced to the point that there are no epidemic-like outbreaks. Glassman estimates that MenAfriVac will prevent a million cases of meningitis in the next decade.

‘The disease has been nipped in the bud as a public health threat,’ she says. Studies in Burkina Faso and Chad confirmed its effectiveness...”

Source Location

Related Experts

Photo of Amanda Glassman
Executive Vice President of CGD, CEO of CGD Europe, and Senior Fellow